FR2711670B1
(fr)
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US20030078223A1
(en)
*
|
1996-01-30 |
2003-04-24 |
Eyal Raz |
Compositions and methods for modulating an immune response
|
EP1537877A3
(en)
|
1996-10-11 |
2005-08-03 |
The Regents Of The University Of California |
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
AU738513B2
(en)
|
1997-02-28 |
2001-09-20 |
University Of Iowa Research Foundation, The |
Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
EP1005368B1
(en)
*
|
1997-03-10 |
2009-09-02 |
Ottawa Hospital Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants
|
US6339068B1
(en)
|
1997-05-20 |
2002-01-15 |
University Of Iowa Research Foundation |
Vectors and methods for immunization or therapeutic protocols
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
JP2001515052A
(ja)
*
|
1997-08-13 |
2001-09-18 |
ザ ユーエイビー リサーチ ファンデーション |
遺伝子ベクターの局所施用によるワクチン接種
|
EP1872786A1
(en)
*
|
1997-09-05 |
2008-01-02 |
The Regents of the University of California |
Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
|
ATE356630T1
(de)
|
1998-04-03 |
2007-04-15 |
Univ Iowa Res Found |
Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
|
DE69927495T2
(de)
*
|
1998-05-14 |
2006-07-06 |
Coley Pharmaceutical Group, Inc., Wellesley |
Verfahren zur regulieren der hämatopoese mit hilfe von cpg-oligonukleotiden
|
IL139813A0
(en)
|
1998-05-22 |
2002-02-10 |
Loeb Health Res Inst At The Ot |
Methods and products for inducing mucosal immunity
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
AU4343700A
(en)
|
1999-04-12 |
2000-11-14 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Oligodeoxynucleotide and its use to induce an immune response
|
US7479285B1
(en)
|
1999-08-19 |
2009-01-20 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
DK1227837T3
(da)
*
|
1999-10-22 |
2008-09-15 |
Aventis Pasteur |
Fremgangsmåde til introduktion og/eller fremskyndelse af et immunrespons på et tumorantigen
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
WO2001051500A1
(en)
|
2000-01-14 |
2001-07-19 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
US6552006B2
(en)
|
2000-01-31 |
2003-04-22 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
US20010046967A1
(en)
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
ATE471374T1
(de)
|
2000-12-27 |
2010-07-15 |
Dynavax Tech Corp |
Immunomodulatorische polynukleotide und verfahren zur deren verwendung
|
US7128911B2
(en)
|
2001-01-19 |
2006-10-31 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of bone disease
|
EP1404873B1
(en)
|
2001-06-21 |
2013-05-22 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
EP1420829A4
(en)
|
2001-08-07 |
2006-05-17 |
Dynavax Tech Corp |
IMMUNOMODULATING COMPOSITIONS, FORMULATIONS AND METHOD FOR THEIR USE
|
AU2002361468A1
(en)
|
2001-08-14 |
2003-03-18 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Method for rapid generation of mature dendritic cells
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
AU2002366710A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
JP2006505523A
(ja)
|
2002-08-12 |
2006-02-16 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節組成物、その製造方法および使用方法
|
US8263091B2
(en)
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
NZ540098A
(en)
|
2002-10-29 |
2008-09-26 |
Coley Pharmaceutical Group Ltd |
Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
|
AU2003304107B2
(en)
|
2002-11-01 |
2008-05-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
|
CA2502015A1
(en)
|
2002-12-11 |
2004-06-24 |
Coley Pharmaceutical Group, Inc. |
5' cpg nucleic acids and methods of use
|
AU2003297483B2
(en)
|
2002-12-23 |
2010-11-18 |
Trisalus Life Sciences, Inc. |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
EP1625140A4
(en)
|
2002-12-23 |
2008-06-18 |
Dynavax Tech Corp |
BRANCHED IMMUNOMODULAR COMPOUNDS AND METHOD OF USE THEREOF
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
US7537767B2
(en)
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
ZA200507063B
(en)
|
2003-03-26 |
2007-03-28 |
Cytos Biotechnology Ag |
Packaging of immunostimulatory oligonucleotides into virus-like particles: Method of preparation and use
|
CA2600036A1
(en)
|
2005-03-04 |
2006-09-14 |
Dynavax Technologies Corporation |
Vaccines comprising oligonucleotides having immunostimulatory sequences (iss) wherein the iss are conjugated to antigens and stabilized by buffer conditions and further excipients
|
JP2008535862A
(ja)
|
2005-04-08 |
2008-09-04 |
キメリクス,インコーポレイテッド |
ポックスウイルス感染の治療のための化合物、組成物および方法
|
DK2269622T3
(en)
|
2005-07-01 |
2014-03-24 |
Index Pharmaceuticals Ab |
CPG OLIGONUCLEOTIDES USED TO INCREASE STEROID ACTIVITY OF A STEROID DEPENDENT PATIENT
|
ES2435531T3
(es)
|
2005-07-01 |
2013-12-20 |
Index Pharmaceuticals Ab |
Modulación de la capacidad de respuesta a los esteroides
|
US8895522B2
(en)
|
2005-10-28 |
2014-11-25 |
Index Pharmaceuticals Ab |
Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
|
US20070184068A1
(en)
|
2005-12-14 |
2007-08-09 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
PL2034015T3
(pl)
*
|
2006-05-31 |
2012-11-30 |
Toray Industries |
Immunostymulujący oligonukleotyd i jego zastosowanie farmaceutyczne
|
ES2427994T3
(es)
|
2006-06-12 |
2013-11-05 |
Cytos Biotechnology Ag |
Procesos para empaquetar oligonucleótidos en partículas de tipo viral de bacteriófagos de ARN
|
CN101636495A
(zh)
|
2006-11-09 |
2010-01-27 |
戴纳瓦克斯技术公司 |
使用免疫刺激性寡核苷酸进行长期的疾病修饰
|
AU2009246169B2
(en)
|
2008-05-15 |
2015-01-22 |
Dynavax Technologies Corporation |
Long term disease modification using immunostimulatory oligonucleotides
|
WO2010078556A1
(en)
|
2009-01-05 |
2010-07-08 |
Epitogenesis Inc. |
Adjuvant compositions and methods of use
|
CN102281892A
(zh)
*
|
2009-01-13 |
2011-12-14 |
特朗斯吉有限公司 |
酿酒酵母线粒体核酸级分用于免疫刺激的用途
|
PT2534150T
(pt)
|
2010-02-12 |
2017-05-02 |
Chimerix Inc |
Métodos para tratar uma infecção viral
|
US20130195919A1
(en)
|
2010-03-05 |
2013-08-01 |
President And Fellows Of Harvard College |
Induced dendritic cell compositions and uses thereof
|
EP2596806A1
(en)
|
2011-11-25 |
2013-05-29 |
Index Pharmaceuticals AB |
Method for prevention of colectomy
|
US9717657B2
(en)
|
2012-10-24 |
2017-08-01 |
Amy Dukoff |
Composition and method of using medicament for endodontic irrigation, stem cell preparations and tissue regeneration
|
BR112015021970A2
(pt)
|
2013-03-14 |
2017-07-18 |
Massachusetts Inst Technology |
composições à base de nanopartículas
|
KR20180014009A
(ko)
|
2015-05-29 |
2018-02-07 |
머크 샤프 앤드 돔 코포레이션 |
암을 치료하기 위한 pd-1 길항제 및 cpg-c 유형 올리고뉴클레오티드의 조합
|
WO2023081486A1
(en)
|
2021-11-08 |
2023-05-11 |
Nurix Therapeutics, Inc. |
Toll-like receptor therapy combinations with cbl-b inhibitor compounds
|